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MagiU and Francis (1), by means of neutralization tests with specific immune 
animal  serum,  demonstrated  that  there  were  antigenic  differences between 
certain strains  of influenza A  virus  (2).  This discovery was  confirmed and 
considerably extended in  subsequent  investigations  by  these  authors  (3,  4) 
and  by Smith  and  Andrewes  (5).  Magill  and  Sugg  (6)  reported  that  with 
human  serum  the  titer  of  neutralizing  antibodies  may  be  dependent  upon 
the virus strain used in the test.  They also reported that during convalescence 
from influenza A neutralizing antibodies against several antigenically different 
strains  of  the  virus  were  increased  though  not  always  to  the  same  extent. 
Taylor and Dreguss (7) obtained essentially similar results.  Andrewes, Smith, 
and  Stuart-Harris  (8)  presented  evidence which  indicated  that  influenza  A 
might also result in the production of antibodies against swine influenza virus. 
This finding was confirmed by Hare and Riehm (9). 
The  fact  that  there  are  quantitative,  though  not  qualitative,  antigenic 
differences between  strains  of influenza A  virus  would  seriously complicate 
the study of immunity to influenza A if it were found that human beings pro- 
duced a relatively strain-specific antibody response to infection by a particular 
virus strain.  On the other hand, if, as seems probable from the results obtained 
by other investigators, there is a broad immunological response to influenza A 
in human beings, the importance to man of antigenic differences between strains 
of the virus diminishes in proportion to the breadth of the antibody response 
and its persistence in time. 
It  is  the  purpose  of  this  paper  to  present  evidence which  indicates  that 
irrespective of the time which elapses after the onset of the disease, there is an 
almost complete lack of strain specificity in the immunological response which 
follows influenza A. 
Materials and Methods 
Sera.--Serum specimens were obtained from five adult patients who were confined 
in one ward of a state institution and who were ill with influenza A at approximately 
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the same time during February, 1939.  The epidemic affecting this institution has 
been described previously (10).  Specimens of serum were taken during the acute 
phase of illness from 2 to 4 days after the onset.  Additional serum specimens were 
obtained approximately 10, 18, and 25 days, as well as 2, 3, 8, and 12 months, following 
the beginning of illness. 
Viruses.--Three antigenic.ally different strains of influenza A virus were used: 
(a)  Strain 399 was isolated from the nasopharyngeal washings of one of the patients 
in this series (Case No. 1).  After 9 serial passages in ferrets this strain was established 
in mice, in which species it was carried through 15 serial passages.  Two suspensions 
of mouse lungs infected with this strain were employed.  The 50 per cent mortality 
end points of these two suspensions were 10  -~'6 and 10  -~'4, respectively. 
(b)  The PR8 strain (11) after preliminary ferret passages had been carried through 
332  serial passages in mice.  The 50 per cent mortality end point of the suspension 
used was 10 -e-5. 
(c)  The W. S. strain (12) was obtained through the courtesy of Dr. C. H. Andrewes. 
Exact data as to the number of animal passages are not available.  The 50 per cent 
mortality end point of the suspension used was 10  -s-9. 
One strain of swine influenza virus (No.  1976),  which was obtained through the 
courtesy of Dr. R. E. Shope, was used.  The suspension had a 50 per cent mortality 
end point of 10  -~'7. 
Standard suspensions of mouse lungs infected with each of the viruses mentioned 
above were prepared as described previously (13) and were stored in a low temperature 
cabinet (14)  at  -76°C. 
Neutralization  Tests.--Neutral~zation  tests with each of the virus strains indicated 
above were carried out on the various serum specimens from each of the five cases of 
influenza A.  The technique of the neutralization test has been described previously 
(10).  A constant quantity of the desired strain of virus was mixed with serial four- 
fold dilutions of serum.  Serum dilution end points and virus titration end points 
were calculated by the 50 per cent mortality method of Reed and Muench (15). 
Neutralizing Capacity.--The neutralizing capacity of each serum against each strain 
of virus was calculated from the results of the neutralization tests by means of the 
equation 
log b =  log y -- (a.log x)  (16) 
EXPERIMENTAL 
The  neutralizing capacities of multiple  serum  specimens  obtained from 
five  cases of influenza A were determined against three antigenically  different 
strains of influenza A  virus and one strain of swine influenza virus. The 
results  are presented in Table I.  It will  be seen that in the serum of Case I, 
from whose nasopharyngeal washings Strain 399 was recovered, there occurred 
an increase in neutralizing  capacity of more than log 2.60 against the homolo- 
gous strain of virus following infection.  Closely similar increases in antibody 
level were  also observed with both the PR8  and W.S. strains of influenza A 
virus, as well as with swine influenza virus. 
It will also be noted that, with the single exception of Case 2, all five cases TABLE  I 
The Neutralizing Capacity of Human Serum against Autigenically Different Strains of Influenza 
A  Virus and Swine In quenza Virus at Intervals Following Influenza A 
Case No. 
1 
(Source of 
strain 399) 
Mean 
all 
cases 
Days after onset 
of illness 
3 
11 
18 
25 
60 
90 
240 
360 
3 
11 
18 
25 
60 
90 
240 
360 
2 
10 
17 
24 
59 
89 
239 
360 
2 
10 
17 
24 
59 
89 
239 
4 
12 
19 
26 
61 
241 
360 
2-4 
10-12 
17-19 
24-26 
59-61 
89-90 
239-241 
360 
Neutralizing capacity of serum against different viruses 
Influenza A virus 
Swine influen~ 
virus  PR 8  W.S.  399 
log 
3.93 or 
6.53 
6.75 
6.53 
5.67 
5.05 
4.94 
4.62 
5.80 
7.62 
7.40 
7.62 
6.53 
6.10 
5.67 
5.74 
5.67 
/og 
4.12 or < 
5.99 
5.99 
6.29 
5.99 
5.70 
4.99 
4.81 
4.00 
4.57 
4.57 
4.43 
4.00 
4.43 
4.57 
4.43 
5.86 
log 
2.36 or < 
4.96 
4.96 
4.96 
4.53 
4.53 
3.67 
1.83 or 
4.27 
4.27 
3.56 
3.41 
3.23 
2.70 
2.70 
4.05 or < 
log 
3.19 
4.93 
4.78 
4.93 
3.92 
4.32 
3.48 
5.97 
7.47 
6.99 
6.56 
6.56 
6.13 
5.83 
6.13 
5.83 
7.62 
7.40 
7.40 
6.53 
6.53 
6.23 
5.80 
4.62 
6.96 
6.53 
5.67 
5.51 
4.80 
4.80 
5.96 
7.70 
7.70 
8.12 
6.53 
5.80 
5.67 
5.20 
7.29 
7.16 
7.07 
6.15 
5.62 
5.49 
5.45 
7.44 
7.59 
7.44 
6.95 
6.95 
6.29 
6.72 
4.12 
5.99 
5.86 
4.99 
4.99 
4.99 
4.81 
6.72 
7.74 
7.84 
7.32 
7.15 
6.72 
6.72 
4.96 
6.35 
6.37 
6.09 
5.81 
5.52 
5.48 
5.67 
or 
6.65 
6.65 
6.65 
5.93 
5.35 
>5.78 
4.92 
3.18 
4.92 
4.92 
4.92 
4.92 
4.05 
4.05 
4.92 
6.21 
5.93 
5.93 
4.92 
4.92 
3.27 
5.40 
5.35 
5.02 
4.94 
4.29 
4.23 
4.18 
7.43 
7.28 
7.28 
6.31 
7.28 
6.56 
6.40 
or <  4.83 
6.13 
6.13 
6.40 
5.54 
5.70 
5.54 
5.26 
6.71 
7.28 
6.30 
6.13 
5.54 
5.02 
6.53 
6.59 
6.29 
6.18 
5.76 
5.68 
5.39 
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were found to have produced almost identical quantities of neutralizing anti- 
bodies against each of the virus strains used.  Although in the sera from Case 2 
similar  concentrations of antibodies were  found against  Strain  399  and  the 
PR8 strain of influenza A virus, as well as swine influenza virus, only a slight 
increase in antibodies was demonstrable against the W.S. strain. 
The  acute  phase  sera  of  the  five  patients  varied  considerably  in  their 
capacities to neutralize the  different virus  strains.  Nevertheless, the  acute 
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FIG. 1.  Mean neutralizing capacities  against three antigenicaUy  different  strains 
of influenza A virus and swine influenza virus of serum obtained from five cases of 
influenza A at intervals after onset. 
phase serum from each individual had a  relatively constant neutralizing ca- 
pacity against  the PR8  and W.S.  strains of influenza A  virus and swine in- 
fluenza virus.  In the acute phase sera of all cases, however, the neutralizing 
capacities against Strain 399 were definitely lower than against the three other 
viruses. 
In Fig. 1 the mean neutralizing capacities of the sera of the five cases against 
each of the  four viruses are  shown graphically.  The mean neutralizing ca- 
pacities have been plotted against  the time after clinical onset at which the 
sera  were  obtained,  and  the  experimental  points  have  been  connected  by 
straight lines.  It seems apparent that in these five cases of influenza A  the 
observed  increases  in  neutralizing  antibody levels  which  followed infection 1~.  L.  ItORS~'AI,L~  yR.,  AND  E.  R.  KICKARD  437 
were as readily demonstrable when one strain of influenza A virus was used 
as when another antigenically different strain was employed.  Furthermore, 
closely similar alterations in antibody levels were also encountered even when 
the antigenically distant swine influenza virus was used in the neutralization 
tests.  It will be observed that  the  shape  of the  mean antibody level time 
curves shown in Fig.  1 were aimost identical irrespective of the strain of in- 
fluenza A virus against which the sera were tested, and that even in the case of 
swine influenza virus, similar alterations in neutralizing antibodies with time 
were  found. 
Not only were the shapes of the antibody level curves similar, but under the 
conditions of these experiments it was found that the mean concentrations of 
neutralizing antibodies, at any interval studied, against the PR8 or W.S. strains 
of influenza A  virus  or even swine  influenza virus  were  not very different. 
However, the mean antibody levels found when Strain 399 of influenza A virus 
was used in neutralization tests were at each interval definitely lower than those 
obtained with the other virus strains.  It will be recalled that Strain 399 was 
recovered from the nasopharyngeal washings of Case 1.  This strain of virus 
was not only causally related to the illness observed in Case 1 but undoubtedly 
was either antigenically very similar, if not identical, to those strains of virus 
which were associated etiologically with the disease encountered in the other 
four cases under study.  It should be pointed out that Strain 399  had been 
carried through only a relatively small number of passages in mice and, there- 
fore, it may not have acquired full virulence for this  species.  Under these 
circumstances the 50 per cent mortality titration end point may not have given 
a fair indication of the quantity of virus present in the suspension.  If a greater 
number of virus particles actually were contained in the suspension than might 
have been expected from the results of the titrations, it seems obvious that the 
determined neutralizing capacity of a  serum would apparently be lower than 
otherwise. 
It has been shown previously (17) that the increased antibody levels which 
follow influenza A  rapidly decline.  The results shown in Fig.  1 present ad- 
ditional evidence in this regard.  It will be seen that even between the  llth 
and the 25th day after onset of the disease there was with each of the strains 
of virus used an indication that  a  slight decrease in antibody concentration 
had occurred.  The progressive lowering of neutralizing capacities continued 
during the 2nd month after onset and was somewhat more rapid during the 3rd 
month.  Between  the  3rd  and  the  12th  months  relatively little  additional 
decrease  in  antibody  level  occurred.  Three  months  after  onset  the  mean 
neutralizing capacity against  the four virus  strains  of the  serum of the five 
cases was only log 0.65 higher than during the first days of their illness, and at 
12 months it was but log 0.45 greater than in the acute phase of the disease. 438  NEUTRALIZING ANTIBODIES AFTER INFLUENZA A 
DISCUSSION 
Quantitative antigenic differences between strains of influenza A virus are 
readily demonstrable in experiments with laboratory animals if tests are carried 
out shortly after primary immunization  (3)  or following initial infection (5). 
However, when longer intervals are allowed to elapse (3), or hyperimmuniza- 
tion is carried out  (4),  or repeated infections are produced  (5,  8),  antigenic 
differences between strains of the virus become less definite or may even be 
undemonstrable.  This  is  usually  taken  to  indicate  that  laboratory strains 
of influenza A virus possess a  number of antigenic components any of which 
may be present in varying concentration but many or most of which are present 
in some concentration in all strains studied. 
Owing to the fact that the majority of normal human beings, unlike normal 
laboratory  animals,  possess  in  their  serum  considerable  quantities  of 
neutralizing antibodies against influenza A virus (18), no matter which strain 
of the virus is used in the test, it seems reasonable to assume that these anti- 
bodies are one expression of previous contact with the virus.  Furthermore, it 
seems probable that by the time adult life is reached the greater proportion of 
human beings may have had a  number of opportunities for contact with the 
virus and that in most instances some of these contacts would have resulted in 
one or more clinical or subclinical infections by the agent.  Under these cir- 
cumstances an attack of influenza A during adult life would be due usually to 
reinfection by the virus and should result in an immunological response similar 
to that observed in hyperimmunized or repeatedly infected laboratory animals. 
The results  of  the  experiments reported herein  indicate  that  there  is  an 
almost complete lack of strain specificity in the neutralizing antibody response 
which follows influenza A in adult human beings.  Furthermore, they indicate 
that the antibodies produced as a result of the infection possess a very broad 
reactivity since the concentrations demonstrable with the antigenically distant 
swine virus were almost identical to those demonstrable with different strains 
of influenza A virus itself.  Finally, it appears that the very rapid and progres- 
sive decrease in  antibody levels which  occurs with increasing time after in- 
fluenza A is not merely the result of a diminution in antibodies directed only 
against  minor  antigenic  components in  the  virus  strain  responsible  for  the 
infection, since this decrease is quantitatively identical whether this strain or 
another is used to determine antibody concentrations. 
S~ARY 
The increased concentrations of neutralizing antibodies against influenza A 
virus in human serum which occur after influenza A  do not differentiate be- 
tween antigenically different strains of this virus or swine influenza virus but 
instead appear to possess equal reactivity against these agents.  The decrease 3F. L. HORS]~ALL, J'R.~ AND E.  R. RICKARD  439 
in antibody levels which occurs with time is also independent of the strain of 
virus used to measure it. 
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